Polycystic ovary syndrome (PCOS) is a
common reproductive endocrine disorder that
affects 5-10% of reproductive-age women
(Knochenhauer ES, 1998). The classic
symptoms of polycystic ovary syndrome
include irregular menstruation, biochemical or
clinical hyperandrogenism, and ultrasound
evidence of polycystic ovaries (Wild RA,
2010). Any woman who displays at least two
of the following three symptoms can be
diagnosed with PCOS, according to the
Rotterdam criteria, which is the one that is
most frequently used. An ultrasound
examination may identify ovarian cysts, ovulation
failure,
biochemical
hyperandrogenism, or hyperandrogenaemia
(Dybciak P, 2022). PCOS increases the risk
of infertility, preeclampsia, early pregnancy
loss, and endometrial cancer in women.
Furthermore, since PCOS is linked to insulin
resistance, evidence suggests that women
with PCOS are more likely to develop type 2
diabetes, dyslipidemia, hypertension, and
heart disease (Bashir, 2020). The cysts are
not harmful, but they do cause hormonal
i mbalances (Watson, 2019). Obesity,
insufficient physical activity, and a family
history of the condition are risk factors. Many
observations may be temporary during this
pubertal transition since various traits may be
changing. Later, during adolescence, many
findings may stabilize (Bashir, 2020). Early
diagnosis and treatment can aid in symptom
control and prevent long-term consequences.
Changes in behavior and lifestyle are part of
PCOS treatment (Gupta, 2018). Many groups
have developed diagnostic standards for this
illness. The National Institutes of Health (NIH)
created the NIH criteria, the American Society
of Reproductive Medicine created the
Rotterdam criteria, and the Androgen Excess
and Polycystic Ovary Syndrome Society
created the AES criteria (AE-PCOS) (Naz MS,
2019). Women who have PCOS are more likely
to experience psychological issues. Studies
conducted in the past have revealed that
PCOS patients have a greater prevalence of
psychiatric diseases, notably mood disorders
(Rasgon NL, 2003). The increased risk of
depression among PCOS-affected women
supports earlier studies. (Rassi A, 2010)
revealed that 26.4% of PCOS patients had
significant depression, and (Hollinrake E,
2007) found that 21% of PCOS patients and
3% of controls had depression. whereas,
(Månsson M, 2008) and (Kerchner A, 2009)
revealed that, correspondingly, 45% and 40%
of PCOS patients had depression. This
variance in depression prevalence between
studies can be attributed to a variety of
screening and diagnosis techniques and
i nstruments, the impact of culture on
depression epidemiology, and ultimately, the
usage of medications like oestrogen (Hussain
A, 2015). (Sadeeqa S, 2018)Conducted
extensive research on PCOS-related mental
stress, indicating that the symptoms of PCOS
most commonly affecting patients include
i ncreased androgen levels, menstrual
disturbances, infertility, obesity, hirsutism, or
alopecia, but behavioral scientists are now
observing significant levels of mental stress
in PCOS patients, particularly among young
girls. This could be because young girls are
more concerned with their physiology and
physical health during adolescence. (Gupta,
2018) This syndrome is a growing concern
among adolescents worldwide, with varying
reports of its prevalence in different parts of
the world. Reports on the prevalence of PCOS
in adolescents are rare. (Joshi B, 2014) In an
Indian study, the prevalence of this syndrome
in 15-19-year-old adolescents was 22.6%
based on the Rotterdam criteria and 9.8%
based on the AE-PCOS criteria. Another study
on adolescents aged 17 to 19 in Thailand
found 5.29% had this syndrome (Kaewnin J,
2018). According to studies conducted in Iran,
the prevalence rate ranges from 8.3% to
11.4% (Asgharnia M, 2011). Studies show
that between 5% and 10% of the general
population worldwide has PCOS (Azziz R,
2004). Depressive symptoms are common in
PCOS patients, especially in young girls, and
are present in about 40% of reproductive-age
women (Kerchner A, 2009). It was found that
4% of people in the southwest of the United
States have PCOS. The incidence was 9.13%
among adolescent Indians (Nidhi R, 2011).
According to the National Institute of Health,
the prevalence of PCOS in adult reproductive
aged women worldwide has increased from
6.5% to 6.8% (Asunción M, 2000). Tabassum
K conducted a study in a hospital in Bangalore and discovered that 10% of women had PCOS.
She also reported a 4.8% prevalence of PCOS
in the 15-24, year age group (Hussain A,
2015). The prevalence of PCOS was reported
to be 22.5% in a study conducted by (Joshi B,
2014) among adolescents and young girls in
Mumbai, India. The prevalence of PCOS in
adolescents was found to be 9.13% in a
residential college in Andhra Pradesh, South
India (Hussain A, 2015). In North India, (Gill
H, 2012) found a prevalence of 3.7% in the
age group of 18-25 years. Adolescent females
with PCOS have more emotional stress and
depression due to obesity, which is the
condition’s primary defining characteristic
(Ibáñez L, 2009). The mechanisms underlying
the relationship between PCOS and anxiety
and depression disorders are unknown
(Dybciak P, 2022). They can be the result of
hormonal changes, PCOS symptoms, or a mix
of the two. New therapy modalities may result
from a better understanding of the risk of
mood problems in women with PCOS.
Therefore, in 2018, the Androgen Excess
Polycystic Ovary Syndrome Society published
a call to action declaring mental health as a
priority for PCOS research (Dokras, et al.,
2018). Natural maturation characteristics
overlap with PCOS signs and symptoms in
adolescent girls (Naz MS, 2019). The condition
is defined by three different sets of diagnostic
criteria in adult women, although their
applicability to adolescents is debatable
(Merino PM, 2018). To the best of our
knowledge, data on PCOS in Kashmir is limited
to a few studies. In 2017, a study found that
the age group 15-24 years had the highest
prevalence of PCOS, i.e., 5.0% (Bashir, 2020).
The researcher team believes that this study
i s necessary because the causes and
consequences of PCOS have previously been
discussed in many studies, but the impact of
the problem on the psycho-social health of
women, particularly adolescent girls, their
experiences, and outcomes has yet to be
investigated, so this study was conducted to
fill that gap.
Asgharnia, M., Mirblook, F., & Soltani, M. A.
(2011). The prevalence of polycystic
ovary syndrome (PCOS) in high school
students in Rasht in 2009 according
to NIH criteria. International journal of
fertility & sterility, 4(4), 156.
Asuncioìn, M., Calvo, R. M., San Millaìn, J. L.,
Sancho, J., Avila, S., & Escobar
Morreale, H. F. (2000). A prospective
study of the prevalence of the
polycystic ovary syndrome in
unselected Caucasian women from
Spain. The Journal of Clinical
Endocrinology & Metabolism, 85(7),
2434-2438.
Azziz, R., Marin, C., Hoq, L., Badamgarav, E.,
& Song, P. (2005). Health care-related
economic burden of the polycystic
ovary syndrome during the
reproductive life span. The Journal of
Clinical
Endocrinology
&
Metabolism, 90(8), 4650-4658.
Azziz, R., Woods, K. S., Reyna, R., Key, T. J.,
Knochenhauer, E. S., & Yildiz, B. O.
(2004). The prevalence and features
of the polycystic ovary syndrome in an
unselected population. The Journal of
Clinical
Endocrinology
&
Metabolism, 89(6), 2745-2749.
Banister, P., Bunn, G., Burman, E., Daniels, J.,
Duckett, P., Goodley, D., … & Whelan,
P. (2011). EBOOK: Qualitative Methods
In Psychology: A Research Guide.
McGraw-Hill Education (UK).
Bashir, R., Bashir, R., Kausar Sideeq, D. S.,
Khan, S., & Masoodi, M. (2020).
Prevalence of polycystic ovarian
syndrome in women of different age
groups in Hazratbal area of Srinagar
by ultrasonographic evaluation
hospital data based study. IJAR, 6(6),
292-295.
Braun, V., & Clarke, V. (2006). Using thematic
analysis in psychology. Qualitative
research in psychology, 3(2), 77-101.
Dantzer, R. (2001). Cytokine-induced sickness
behavior: where do we stand?. Brain,
behavior, and immunity, 15(1), 7-24.
Dokras, A., Stener-Victorin, E., Yildiz, B. O.,
Li, R., Ottey, S., Shah, D., … & Teede,
H. (2018). Androgen Excess-Polycystic
Ovary Syndrome Society: position
statement on depression, anxiety,
quality of life, and eating disorders in
polycystic ovary syndrome. Fertility
and sterility, 109(5), 888-899.
Dybciak, P., Humeniuk, E., Raczkiewicz, D.,
Krakowiak, J., Wdowiak, A., & Bojar,
I. (2022). Anxiety and Depression in
Women with Polycystic Ovary
Syndrome. Medicina, 58(7), 942.
Gill, H., Tiwari, P., & Dabadghao, P. (2012).
Prevalence of polycystic ovary
syndrome in young women from North India:
A
Community-based
study. Indian journal of endocrinology
and metabolism, 16(Suppl 2), S389.
Gupta, M., Singh, D., Toppo, M., Priya, A.,
Sethia, S., & Gupta, P. (2018). A cross
sectional study of polycystic ovarian
syndrome among young women in
Bhopal, Central India. Int J Community
Med Public Health, 5(1), 95-100.
Hachul, H., Polesel, D. N., Tock, L., Carneiro,
G., Pereira, A. Z., Zanella, M. T., … &
Togeiro, S. M. (2019). Sleep disorders
i n polycystic ovary syndrome:
i nfluence
of
obesity
and
hyperandrogenism. Revista da
Associação Médica Brasileira, 65,
375-383.
Hollinrake, E., Abreu, A., Maifeld, M., Van
Voorhis, B. J., & Dokras, A. (2007).
Increased risk of depressive disorders
i n women with polycystic ovary
syndrome. Fertility and sterility, 87(6),
1369-1376.
Hussain, A., Chandel, R. K., Ganie, M. A., Dar,
M. A., Rather, Y. H., Wani, Z. A., … &
Shah, M. S. (2015). Prevalence of
psychiatric disorders in patients with
a diagnosis of polycystic ovary
syndrome in Kashmir. Indian journal of
psychological medicine, 37(1), 66-70.
Ibáñez, L., Díaz, R., López-Bermejo, A., &
Marcos, M. V. (2009). Clinical
spectrum of premature pubarche:
links to metabolic syndrome and
ovarian hyperandrogenism. Reviews
i n
Endocrine and Metabolic
Disorders, 10, 63-76.
Joshi, B., Mukherjee, S., Patil, A., Purandare,
A., Chauhan, S., & Vaidya, R. (2014).
A cross-sectional study of polycystic
ovarian syndrome among adolescent
and young girls in Mumbai,
India. Indian journal of endocrinology
and metabolism, 18(3), 317.
Kaewnin, J., Vallibhakara, O., Arj-Ong
Vallibhakara, S., Wattanakrai, P.,
Butsripoom, B., Somsook, E., … &
Sophonsritsuk, A. (2018). Prevalence
of polycystic ovary syndrome in Thai
University adolescents. Gynecological
Endocrinology, 34(6), 476-480.
Kerchner, A., Lester, W., Stuart, S. P., &
Dokras, A. (2009). Risk of depression
and other mental health disorders in
women with polycystic ovary
syndrome:
a
l ongitudinal
study. Fertility and sterility, 91(1),
207-212.
Knochenhauer, E. S., Key, T. J., Kahsar-Miller,
M., Waggoner, W., Boots, L. R., &
Azziz, R. (1998). Prevalence of the
polycystic ovary syndrome in
unselected black and white women of
the southeastern United States: a
prospective study. The Journal of
Clinical
Endocrinology
&
Metabolism, 83(9), 3078-3082.
Månsson, M., Holte, J., Landin-Wilhelmsen, K.,
Dahlgren, E., Johansson, A., & Landén,
M. (2008). Women with polycystic
ovary syndrome are often depressed
or anxious—a case control
study. Psychoneuroendocrinology, 33(8),
1132-1138.
McCook, J. G., Reame, N. E., & Thatcher, S.
S. (2005). Health related quality of life
issues in women with polycystic ovary
syndrome. Journal of Obstetric,
Gynecologic,
&
Neonatal
Nursing, 34(1), 12-20.
Merino, P. M., Codner, E., & Cassorla, F.
(2011). A rational approach to the
diagnosis of polycystic ovarian
syndrome
during
adolescence. Arquivos Brasileiros de
Endocrinologia & Metabologia, 55,
590-598.
Moran, L. J., Pasquali, R., Teede, H. J., Hoeger,
K. M., & Norman, R. J. (2009).
Treatment of obesity in polycystic ovary syndrome: a position statement
of the Androgen Excess and Polycystic
Ovary Syndrome Society. Fertility and
sterility, 92(6), 1966-1982.
Morse, J. M. (2008). Confusing categories and
t hemes. Qualitative
health
research, 18(6), 727-728.
Naz, M. S. G., Tehrani, F. R., Majd, H. A.,
Ahmadi, F., Ozgoli, G., Fakari, F. R., &
Ghasemi, V. (2019). The prevalence
of polycystic ovary syndrome in
adolescents: A systematic review and
meta-analysis. International Journal of
Reproductive BioMedicine, 17(8), 533.
Nidhi, R., Padmalatha, V., Nagarathna, R., &
Amritanshu, R. (2011). Prevalence of
polycystic ovarian syndrome in Indian
adolescents. Journal of pediatric and
adolescent gynecology, 24(4), 223
227.
Rasgon, N. L., Rao, R. C., Hwang, S., Altshuler,
L. L., Elman, S., Zuckerbrow-Miller, J.,
& Korenman, S. G. (2003). Depression
i n women with polycystic ovary
syndrome: clinical and biochemical
correlates. Journal of affective
disorders, 74(3), 299-304.
Rassi, A., Veras, A. B., dos Reis, M., Pastore,
D. L., Bruno, L. M., Bruno, R. V., … &
Nardi, A. E. (2010). Prevalence of
psychiatric disorders in patients with
polycystic
ovary
s y n drome. Comprehensive
psychiatry, 51(6), 599-602.
Sadeeqa, S., Mustafa, T., & Latif, S. (2018).
Polycystic ovarian syndrome–related
depression in adolescent girls: a
review. Journal of pharmacy &
bioallied sciences, 10(2), 55.
Veldhuis, J. D., Pincus, S. M., Garcia-Rudaz,
M. C., Ropelato, M. G., Escobar, M. E.,
& Barontini, M. (2001). Disruption of
the joint synchrony of luteinizing
hormone, testosterone, and
androstenedione secretion in
adolescents with polycystic ovarian
syndrome. The Journal of Clinical
Endocrinology & Metabolism, 86(1),
72-79.
Watson, S. (2019). Polycystic Ovary Syndrome
(PCOS): Symptoms, Causes, and
Treatment.
Wild, R. A., Carmina, E., Diamanti-Kandarakis,
E., Dokras, A., Escobar-Morreale, H.
F., Futterweit, W., … & Dumesic, D.
A.
(2010).
Assessment of
cardiovascular risk and prevention of
cardiovascular disease in women with
the polycystic ovary syndrome: a
consensus statement by the Androgen
Excess and Polycystic Ovary Syndrome
(AE-PCOS) Society. The Journal of
Clinical
Endocrinology
&
Metabolism, 95(5), 2038-2049.
Williams, S. (2018). A Critical Realist
informed Thematic Analysis: Families’
experience of the process of
adjustment when a family member is
i n a forensic mental health
hospital (Doctoral dissertation,
University of East London).